BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250402T120000
DTEND;TZID=Europe/Brussels:20250402T130000
DTSTAMP:20260526T143102
CREATED:20250307T125629Z
LAST-MODIFIED:20250307T130948Z
UID:8854-1743595200-1743598800@www.europabio.org
SUMMARY:A Biotech & Life-Sciences Roadmap: how investment can reach European Start-ups and Scale-ups?
DESCRIPTION:Europe is set for a wave of long-awaited policy action in the biotech and life sciences sectors – including through a European Startup and Scaleup Strategy\, a Life Sciences Strategy\, and a Biotech Act. \n\n\n\nMarking Poland’s Council Presidency of the European Union\, EuropaBio National Associations Council is excited to bring you the latest edition of its usual Council Presidency Summit! \n\n\n\nThis time\, in person in Warsaw\, in an informal setting\, we will explore the key elements of a successful national strategy for the life sciences sector and how Europe can better support its startups and scaleups to make them globally competitive. We will also explore how to bridge Eastern Europe and the Baltic nations with Western Europe\, building a truly single market for biotech and life sciences products. \n\n\n\nThis discussion will be co-hosted with the Polish biotechnology association BioForum. It will be part of its upcoming CEBioForum event 2025. \n\n\n\nIf you wish for further information\, and you will be attending CEBioForum\, feel free to drop a message to José Peres at j.peres@europabio.org. \n\n\n\nLocation: CIC\, Chmielna 73\, Warsaw\, Poland. \n\n\n\n\nMore info here
URL:https://www.europabio.org/event/a-biotech-life-sciences-roadmap-how-investment-can-reach-european-start-ups-and-scale-ups/
CATEGORIES:EuropaBio,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/03/EuropaBio-Event-Banner-Templates-2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250402T080000
DTEND;TZID=Europe/Brussels:20250403T200000
DTSTAMP:20260526T143102
CREATED:20241204T130548Z
LAST-MODIFIED:20250217T103806Z
UID:8517-1743580800-1743710400@www.europabio.org
SUMMARY:CEBioForum 2025
DESCRIPTION:We warmly invite you to participate in CEBioForum 2025\, one of the key events for business and science in the biotechnology sector in Central Europe! \n\n\n\nOn April 2-3\, 2025\, at the Cambridge Innovation Center in Warsaw\, biotechnology innovation leaders\, scientists\, companies\, and investors will gather to share knowledge\, experiences\, and form new partnerships. \n\n\n\nWhy should you attend CEBioForum? \n\n\n\n\nBusiness networking – Our conference brings together representatives from over 170 biotech companies\, research institutes\, and investors from 21 countries. It’s a perfect opportunity to expand your network\, establish collaborations\, and unlock new business opportunities\, including through our dedicated B2B meeting application.\n\n\n\nExpert insights – Presentations and discussion panels featuring international guests and led by top industry experts. Learn about the latest trends in biotechnology\, innovation financing\, commercialization of inventions\, and expansion into foreign markets.\n\n\n\nLatest innovations – Discover best practices and the newest technological advancements that can accelerate the growth of your company. Explore new funding opportunities and support for research projects.\n\n\n\nShowcase your business – CEBioForum offers a unique chance to present your products and services to a wider audience and investors\, either through presentations or an exhibition booth in our showcase area.\n\n\n\n\nFor over 20 years\, CEBioForum has been connecting scientific and business communities\, creating a space for collaboration and the development of biotechnology projects. Join us and become part of the community shaping the future of biotechnology in Central and Eastern Europe! \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/cebioforum-2025/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/12/External-Events-Banners-600-×-200px-CEBioForum-2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250311T083000
DTEND;TZID=Europe/Brussels:20250313T173000
DTSTAMP:20260526T143102
CREATED:20240710T134750Z
LAST-MODIFIED:20240910T125522Z
UID:8038-1741681800-1741887000@www.europabio.org
SUMMARY:EFIB at BIOKET 2025
DESCRIPTION:The Bioeconomy’s Key Enabling Technologies Conference & Exhibition \n\n\n\nEuropaBio is thrilled to announce that the European Forum for Industrial Biotechnology (EFIB)\, and ACDV are joining forces with BIOKET 2025 in Brussels from March 11-13. This collaboration brings a significant policy-making component to our event\, providing an unparalleled opportunity to shape the bioeconomy sector’s future. \n\n\n\nJoin us on March 11th for an impactful Open Plenary Session dedicated to Policy Makers:  \n\n\n\nBiotechnology & Biomanufacturing for Europe: Building a critical EU future \n\n\n\n\n\n\n\nBiotechnology and Biomanufacturing are changing industrial ecosystems within a global race to establish resilient supply chains and competitive positions. BIOKET arrives at the heart of Europe with the technologies that drive progress and the companies that deliver outcomes. Our opening plenary will address EU ambition\, industrial strategy and the framework needed for Europe to play its full role on the world stage and shape a competitive and resilient future for the European and global bioeconomy. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/efib-at-bioket-2025/
CATEGORIES:EFIB,EuropaBio
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/07/Resize-image-project.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250306T080000
DTEND;TZID=Europe/Brussels:20250307T200000
DTSTAMP:20260526T143102
CREATED:20250128T152232Z
LAST-MODIFIED:20250217T103737Z
UID:8625-1741248000-1741377600@www.europabio.org
SUMMARY:4th Hellenic Biocluster Forum: Emerging Trends in Life Science Innovation
DESCRIPTION:Join the 4th Hellenic Biocluster Forum for a 2-day programme discussing all the emerging trends in Life Science Innovation! Get the opportunity to meet stakeholders from the Greek and European innovation ecosystems through B2B partnering opportunities\, meet exhibitors showcasing the latest technology\, pitch to investors and connect to SMEs\, service providers\, big pharma\, and academic institutions. \n\n\n\nKeynote Speakers & RoundTables on: Scaling-up Biotechnology Innovation\, Investment\, Big Data & AI\, Precision Medicine\, Innovative Healthcare\, Bio-Manufacturing\, Technology Transfer into the Market \n\n\n\nWhy do you need to be at the 4th HBio Forum? \n\n\n\n\nA 2-day\, cutting-edge programme on the emerging trends in Life Sciences\n\n\n\nPhysical and digital B2B\n\n\n\nPartnering Opportunities\n\n\n\nExhibition Booths\n\n\n\nOpportunity to meet and present your idea to innovators\, policy makers and investors\n\n\n\nAttend site-visits to Research and Industry partners\n\n\n\n\nWho should attend? \n\n\n\n\nInnovators from SMEs\, startups\, spinoffs\, big pharma\, academia\,\n\n\n\nLife Sciences Clusters and Innovation Agencies\n\n\n\nService Providers\n\n\n\nPolicy Makers\n\n\n\nInvestors\n\n\n\n\nWhat to expect? \n\n\n\n\nGlobal Networking with innovators from across Greece\, Europe and around the globe\n\n\n\nExpert Insights into the latest trends\, technologies and best practices in Life Sciences\n\n\n\nInvestor Connections and Pitch your idea\n\n\n\nOpportunities Exploring Athens!\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/4th-hellenic-biocluster-forum-emerging-trends-in-life-science-innovation/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2025/01/Event-Banners-Website-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250228T090000
DTEND;TZID=Europe/Brussels:20250228T103000
DTSTAMP:20260526T143102
CREATED:20250211T094956Z
LAST-MODIFIED:20250211T094957Z
UID:8724-1740733200-1740738600@www.europabio.org
SUMMARY:B-Trust’s 2nd  masterclass: Co-Creating Trust in Biotech – Cell Factories
DESCRIPTION:How can biotechnology help shape a more sustainable food system? While scientific advancements are creating greener and more innovative ingredients\, gaining consumer trust remains a key challenge.In this exclusive online masterclass\, we’ll explore the role of cell factories – microorganisms that produce specialty food ingredients through fermentation – and their potential to revolutionise food production while reducing land use\, water consumption\, and carbon emissions. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/b-trusts-2nd-masterclass-co-creating-trust-in-biotech-cell-factories/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/02/Event-Banners-Website-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250129T183000
DTEND;TZID=Europe/Brussels:20250129T203000
DTSTAMP:20260526T143102
CREATED:20241217T125548Z
LAST-MODIFIED:20250128T102313Z
UID:8543-1738175400-1738182600@www.europabio.org
SUMMARY:A Driver of European Competitiveness: The Future of European Biotech
DESCRIPTION:EuropaBio\, the European association representing Bioindustries\, will host an evening reception co-hosted by MEP Stine Bosse (Vice-Chair\, SANT) and MEP Eszter Lakos (Member\, ITRE)\, to discuss the role of the European biotech sector in making the European industry more competitive. \n\n\n\nAmbassador Søren Jacobsen\, Deputy Permanent Representative of Denmark to the EU\, and Kristin Schreiber\, Director at DG GROW\, Klaus Berend\, Director SANTE will share some remarks on their approach to the biotech sector in the new mandate. \n\n\n\nThis event is only open to EuropaBio members & invited guests\, to find out more about EuropaBio membership\, contact us through our website here.
URL:https://www.europabio.org/event/a-driver-of-european-competitiveness-the-future-of-european-biotech/
CATEGORIES:Biomanufacturing Platform,EuropaBio,Healthcare Biotech,Industrial Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/12/EUROPABIO.6788f179502696.54888785.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250128T140000
DTEND;TZID=Europe/Brussels:20250128T180000
DTSTAMP:20260526T143102
CREATED:20241126T083629Z
LAST-MODIFIED:20241126T083631Z
UID:8485-1738072800-1738087200@www.europabio.org
SUMMARY:EU Health Summit
DESCRIPTION:Healthy populations are essential for Europe to achieve its vision of a secure\, competitive\, and prosperous continent. Yet\, European health systems are navigating a perfect storm: ageing populations\, rising chronic diseases\, and a health workforce under strain. European societies are facing combined cost-of-living\, geopolitical\, and climate crises with significant implications for healthcare. \n\n\n\nAmid these challenges\, we must not lose sight of the extraordinary era we are living in—one of rapidly advancing science and innovation\, transforming health and unlocking new possibilities for Europe’s present and future generations. \n\n\n\nKeeping the health sector high on the political agenda is essential for the well-being of Europeans\, a resilient workforce\, the growth of the EU economy\, and the security of Europe. This is why\, during this EU mandate\, we need a robust and integrated strategy for health policy. \n\n\n\nWhat needs to be done in practice? \n\n\n\nJoin the EU Health Summit on 28 January to help shape a roadmap for a healthier Europe. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/eu-health-summit/
CATEGORIES:EuropaBio,External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/External-Events-Banners-600-×-200px-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241225T080000
DTEND;TZID=Europe/Brussels:20241227T200000
DTSTAMP:20260526T143102
CREATED:20241113T103614Z
LAST-MODIFIED:20241113T103616Z
UID:8467-1735113600-1735329600@www.europabio.org
SUMMARY:2nd ESAB Digital Congress
DESCRIPTION:After the successful first digital ESAB Congress last year\, the Scientific Committee has decided that a digital ESAB congress will take place again this year from November 25-27. \n\n\n\nDeadline for abstract submission: 31 October 2024 \n\n\n\nESAB Aims \n\n\n\n\nto take initiatives in areas of growing scientific and industrial interest and importance in the field of applied biocatalysis\n\n\n\n\n\nto identify key topics which may be rate-limiting in the development of scientific progress and technological prospects in applied biocatalysis and to take steps to stimulate these areas\n\n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/2nd-esab-digital-congress/
CATEGORIES:Biomanufacturing Platform,External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/Event-Banner-E-Congress-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241210T080000
DTEND;TZID=Europe/Brussels:20241211T200000
DTSTAMP:20260526T143102
CREATED:20240531T115038Z
LAST-MODIFIED:20240603T072409Z
UID:7883-1733817600-1733947200@www.europabio.org
SUMMARY:The European Bioplastics Conference 2024
DESCRIPTION:We are happy to announce that the EBC 24 will take place on 10/11 December 2024 at the Titanic Hotel Berlin\, Germany.    \n\n\n\nThe European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers\, and policy makers are increasingly streamlining their efforts to create frameworks that benefit the growth of sustainable bio-industries. Now is the time to put bioplastics at the top of the agenda of a biobased circular economy in Europe and beyond. \n\n\n\nThe registration for the EBC 24 is now open and we are excited to welcome you on 10/11 December 2024 in Berlin or online. \n\n\n\nThe hybrid format of this year’s event will again allow you to join either in person at the Titanic Hotel Berlin or comfortably log-in from your home base. Both of which offer unique networking opportunities. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/the-european-bioplastics-conference-2024/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/05/External-Events-Banners-600-×-200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241122T140000
DTEND;TZID=Europe/Brussels:20241122T160000
DTSTAMP:20260526T143102
CREATED:20241125T083939Z
LAST-MODIFIED:20241125T083942Z
UID:8482-1732284000-1732291200@www.europabio.org
SUMMARY:What's Next for Biotech & Biosecurity: EU & US Post Election Landscape
DESCRIPTION:Join our Healthcare Public Affairs Director\, Vlad Olteanu on Friday 22nd November to listen to What’s next for Biotech and Biosecurity in the EU & US post elections.  \n\n\n\n\nMore information & Registerion Here
URL:https://www.europabio.org/event/whats-next-for-biotech-biosecurity-eu-us-post-election-landscape/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/External-Events-Banners-600-×-200px-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241119T080000
DTEND;TZID=Europe/Brussels:20241119T200000
DTSTAMP:20260526T143102
CREATED:20240619T110353Z
LAST-MODIFIED:20240619T110641Z
UID:7976-1732003200-1732046400@www.europabio.org
SUMMARY:AseBio Green Innovation Forum
DESCRIPTION:Organized by AseBio\, the Spanish Bioindustry Association\, and Sodena the financial agent of the Government of Navarra\, the 5th edition of the AseBio Green Innovation Forum will be held in the Baluarte convention centerof Pamplona on November 19\, 2024. The event will showcase the opportunities that biotechnology can offer as a key tool in the transition towards a more sustainable\, carbon neutral and greener economic model.  The Green Innovation Forum is also firmly committed to achieving the objectives set out in the 2030 Agenda and the European Green Deal. The AseBio Green Innovation Forum will have an agenda of round tables and business meetings in which to address the most relevant aspects of innovation in biotechnology and the green economy. We will also seek to find solutions to medium-long term challenges such as climate change\, industrial transformation\, sustainable food\, or the development of bio-products\, among others. RegistrationRegistration for the Green Innovation Forum 24 is now open. Take advantage of the early bird rates until July 31st. \n\n\n\nPresent your companyCompanies that are members of AseBio or domiciled in Navarra can submit a proposal to present their company before an audience of specialized investors and companies at no extra cost of your registration fee. Sinx-minute presentations will be delivered onsite on November 19th\, 2024. Not all applications will be accepted. A selection committee will review and accept or decline all applications. The deadline to apply: is September 20\, 2024 \n\n\n\nIf you wish to become a member of AseBio please visit our website. \n\n\n\nSponsorship opportunities \n\n\n\nDo you wish to become a sponsor of the Green Innovation Forum? \n\n\n\nGreeen Innovation Forum 2024 will provide you with a unique opportunity to meet face-to-face within Spanish and international  cutting edge companies and research institutions in the green biotech space. \n\n\n\nSponsoring the event will help to create interest in your company\, products and services and also: \n\n\n\n\nRaise your profile within the Spanish and European biotech industry.\n\n\n\n\n\nOther benefits\, as included in the different sponsorship packages.\n\n\n\n\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/asebio-green-innovation-forum/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/06/External-Events-Banners-600-×-200px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241119T000000
DTEND;TZID=Europe/Brussels:20241119T235959
DTSTAMP:20260526T143102
CREATED:20241029T130646Z
LAST-MODIFIED:20241030T124012Z
UID:8442-1731974400-1732060799@www.europabio.org
SUMMARY:SME roundtable: Towards globally competitive European SMEs
DESCRIPTION:Europe is home to a vibrant community of Biotechnology SMEs contributing to the modernisation of the European industry. European biotechnology SMEs are the main drivers for innovation in healthcare\, food and feed\, industrial processes and manufacturing. \n\n\n\nThe Initiative on “Boosting Biotechnology and Biomanufacturing in the EU” published by the European Commission in March 2024 provides great prospects for EU SMEs. It highlights the EU ambition to deliver the benefits of biotechnology to support EU competitiveness and innovation alongside other global regions. One objective of the initiative is to identify ways to streamline EU legislation and its implementation to reduce Single Market fragmentation\, explore potential simplification of regulatory processes\, and shortening the time to market of biotechnological innovations. \n\n\n\nIn order to meet this objective\, EuropaBio\, the voice of biotechnology industries in Europe\, will be hosting this roundtable to work as partners with all relevant stakeholders to guarantee the success of this Initiative. This roundtable session aims to provide a discussion forum for SME participants active in the sector to share their main driving forces and obstacles to accessing global markets and supply chains. The session will explore the essential elements required to speed up EU market access of biotech products.  \n\n\n\nThis event will be followed by a dedicated report exploring the sessions outcomes. \n\n\n\nFor more information\, contact: communications@europabio.org
URL:https://www.europabio.org/event/sme-roundtable-towards-globally-competitive-european-smes/
CATEGORIES:EFIB,EuropaBio,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241112T090000
DTEND;TZID=Europe/Brussels:20241112T123000
DTSTAMP:20260526T143102
CREATED:20241029T085347Z
LAST-MODIFIED:20241029T085348Z
UID:8437-1731402000-1731414600@www.europabio.org
SUMMARY:Advancing bio-based innovations in the food industry: Focus on fermentation
DESCRIPTION:Join our Director General Dr Claire Skentelbery on the 12th of November in Brussels where she will be speaking at the DG GROW hosted hybrid workshop “Advancing bio-based innovations in the food industry: Focus on fermentation”. \n\n\n\nThe workshop will focus on the industrial applications of fermentation technologies by highlighting SMEs that are using biomass\, precision and gas fermentation. Their innovative technologies will be presented\, along with ways to promote scaling up production. These presentations will be followed by a Q&A session. \n\n\n\nAfter these industry insights\, a panel of experts will discuss topics such as research and innovation\, infrastructure\, the role of farmers\, public acceptance\, market development\, and profitability and pricing. In addition to the fermentation types presented at the beginning of the workshop\, micro fermentation will be discussed. \n\n\n\nDeadline for registrations: 4 November 2024 \n\n\n\n\nMore Information & Register Here
URL:https://www.europabio.org/event/advancing-bio-based-innovations-in-the-food-industry-focus-on-fermentation/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241104T080000
DTEND;TZID=Europe/Brussels:20241106T200000
DTSTAMP:20260526T143102
CREATED:20241009T073025Z
LAST-MODIFIED:20241009T074047Z
UID:8389-1730707200-1730923200@www.europabio.org
SUMMARY:BIO-Europe® 2024
DESCRIPTION:BIO-Europe® 2024 – 30th Annual International Partnering Conference  \n\n\n\nDates:November 4-6\, 2024 | Stockholm\, SwedenNovember 12–13\, 2024 | Digital PartneringVenue: Stockholmsmässan \n\n\n\nVenue address: Mässvägen 1\, 125 80 Stockholm Sweden \n\n\n\nJoin the 30th anniversary edition of BIO-Europe\, the biopharma partnering event that has grown with the industry\, innovated alongside it\, and remains the gathering place for meaningful and memorable conversations and connections. In 2023\, BIO-Europe reached new levels of attendance\, engagement\, and collaboration. 2024 promises to deliver quality opportunities for connection and partnering. The 30th annual BIO-Europe will take place November 4-6\, 2024 in Stockholm\, Sweden\, and it will convene over 5\,500 life science professionals representing more than 2\,800 companies from over 60 countries. Attendees will take part in 29\,000 one-to-one meetings over the course of the event. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-europe-2024/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241023T080000
DTEND;TZID=Europe/Brussels:20241024T200000
DTSTAMP:20260526T143102
CREATED:20241003T082016Z
LAST-MODIFIED:20241003T082123Z
UID:8368-1729670400-1729800000@www.europabio.org
SUMMARY:Regulating the Future of Food Conference
DESCRIPTION:Join our Industrial Biotechnology Senior Manager Lucie McMurtry on the 23rd and 24th of October in Amsterdam where she will be speaking at the Regulating the Future of Food Conference. \n\n\n\nGlobal innovation in food-tech is growing at an incredible pace and there are so many amazing new products and processes out there! This innovation is vital in making a difference to the planet by creating more sustainable and ‘greener’ food systems\, whilst also contributing to economic growth. \n\n\n\nRegulators are doing their best to keep up. They are all working on ways to evolve in line with innovation and create more effective and efficient ways to regulate novel foods\, whilst keeping safety as the key priority. However\, regulations are often seen as a barrier to innovation due to complex frameworks\, a lack of clear guidance and long evaluation timelines. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/regulating-the-future-of-food-conference/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/Healthcare-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241022T080000
DTEND;TZID=Europe/Brussels:20241025T170000
DTSTAMP:20260526T143102
CREATED:20240611T071159Z
LAST-MODIFIED:20240611T071200Z
UID:7930-1729584000-1729875600@www.europabio.org
SUMMARY:World Orphan Drug Congress Europe 2024
DESCRIPTION:The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees\, hear from 250 leading speakers\, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From regulation and policy to global pricing and gene therapy\, the Congress has it covered. \n\n\n\nOur attendees include the most senior individuals across the industry\, including; R&D\, Gene Therapy and Rare diseases\, Precision/Personalised Medicine\, Genetic Disorders\, Patient Advocacy and Engagement\, Associations in ATMPs\, Investors\, Regulatory Affairs Professionals\, Governmental Bodies and many more … \n\n\n\nUse code “EUBIO20” to save an additional 20% off the Pharma/Biotech and Standard packages.
URL:https://www.europabio.org/event/world-orphan-drug-congress-europe-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/06/Event-Website-Banner-EBIO-WODC-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241008T100000
DTEND;TZID=Europe/Brussels:20241010T180000
DTSTAMP:20260526T143102
CREATED:20240828T135105Z
LAST-MODIFIED:20240828T135930Z
UID:8158-1728381600-1728583200@www.europabio.org
SUMMARY:CPHI Milan
DESCRIPTION:EuropaBio is pleased to partner with CPHI Milan 2024\, the biggest international pharmaceutical industry event for the thirty fifth anniversary edition. This year’s edition held from the 8th to the 10th of October in Fiera Milano\, Italy promises to a packed agenda with over 150 expert international speakers with over 100 content sessions. \n\n\n\nJoin our Director General Dr Claire Skentelbery this year where she will be speaking on the 9th of October to discuss how cultivated meat has the potential to revolutionise biologic manufacturing. Join her in Hall 3 – 3F97 at 16:15 on 09/10/2024 to find out more. \n\n\n\n \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/cphi-milan/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/CPHI-x-EuropaBio-2024-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241002T170000
DTEND;TZID=Europe/Brussels:20241002T193000
DTSTAMP:20260526T143102
CREATED:20240827T080153Z
LAST-MODIFIED:20240827T080535Z
UID:8151-1727888400-1727897400@www.europabio.org
SUMMARY:Enhancing Europe's Pharma and Biotech Competitiveness and Open Strategic Autonomy
DESCRIPTION:Join our Director General Dr Claire Skentelbery on 2 October 2024 where she will be speaking at the Novartis & BritCham event “Enhancing Europe’s Pharma and Biotech Competitiveness and Open Strategic Autonomy”. \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/enhancing-europes-pharma-and-biotech-competitiveness-and-open-strategic-autonomy/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/BritCham-Novartis-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241001T170000
DTEND;TZID=Europe/Brussels:20241001T200000
DTSTAMP:20260526T143102
CREATED:20240517T115325Z
LAST-MODIFIED:20240517T115327Z
UID:7794-1727802000-1727812800@www.europabio.org
SUMMARY:Europe's Biotechnology & Biomanufacturing Future
DESCRIPTION:Biotechnology is a critical technology for global economic security\, health and sustainability. \n\n\n\nEurope’s world-leading research is translated into medicines\, food and next generation biomanufacturing across sectors in all European regions\, with employment\, skills and economic growth as part of a more sustainable\, healthy\, autonomous and competitive Europe. \n\n\n\nThe importance of biotechnology to Europe is now recognised through multiple actions. The European Commission Initiative “Boosting Biotechnology and Biomanufacturing in the EU” highlights the EU ambition to deliver biotechnology for competitiveness and societal impact alongside fast moving global regions\, whilst the Letta report highlights its significance within a well-functioning single market. It is amplified further through its specific inclusion in legislations such as STEP and the Net Zero Industry Act. \n\n\n\nEuropaBio\, the voice of biotechnology industries in Europe\, will be hosting this reception to explore how biotechnology is used across sectors. Invited guests will meet the European innovators that deliver and use biotechnology and understand how it benefits the quality of life of all EU citizens. \n\n\n\nInnovative companies plus national and regional biotechnology associations will share their knowledge\, and guests will network across EU Institutions and other key stakeholders to discover how the European Union builds the future of biotechnology. \n\n\n\nFor more information\, contact: communications@europabio.org
URL:https://www.europabio.org/event/europes-biotechnology-biomanufacturing-future/
CATEGORIES:Biotech Week,EuropaBio
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Event-Banner-for-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240930T140000
DTEND;TZID=Europe/Brussels:20240930T160000
DTSTAMP:20260526T143102
CREATED:20240719T161756Z
LAST-MODIFIED:20240927T055832Z
UID:8081-1727704800-1727712000@www.europabio.org
SUMMARY:How does a Novel Food get to your plate?
DESCRIPTION:This EuropaBio’s webinar will focus on the pathway to market for Novel Foods\, from initial development in R&D through to consumer uptake while going through risk assessment and approval. Each speaker will cover a key point along the value chain\, including illustrative examples and case studies where relevant.    \n\n\n\nThe event will be moderated by Hannah Lester\, CEO at Atova Consulting.  \n\n\n\nThe confirmed speakers are: \n\n\n\n\nMuriel Dewilde\, Business Development Manager\, Bio Base Europe Pilot Plant\n\n\n\nErmolaos Ververis\, Scientific Officer Nutrition & Food Innovation Unit\, EFSA\n\n\n\nTimen Van Haaster\, Public Affairs & Communications Director\, HollandBio\n\n\n\nAnders Nelving\, Line Solution Manager\, Tetra Pak\n\n\n\nPer Falholt\, CSO at 21st Bio\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/how-does-a-novel-food-get-to-your-plate/
CATEGORIES:Biotech Week,EuropaBio
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/07/banner-website.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240924T140000
DTEND;TZID=Europe/Brussels:20240924T153000
DTSTAMP:20260526T143102
CREATED:20240604T072713Z
LAST-MODIFIED:20240919T083820Z
UID:7902-1727186400-1727191800@www.europabio.org
SUMMARY:The Future of Biotech: The Role of Legislation within Investment for Innovation
DESCRIPTION:To celebrate the start of European Biotech Week 2024\, EuropaBio is organising a webinar to discuss the critical intersection of legislation and investment into innovation within the biotech industry. With clear political support for European leadership in biotech\, ensuring EU legislation become key enabler of investment for innovation will be essential to the EU’s global competitiveness and strategic open autonomy. \n\n\n\nThis webinar will bring together representatives from the biotech industry\, investor community\, and European institutions to explore the essential elements required to foster a thriving biotech and life sciences ecosystem in the EU. \n\n\n\nThe confirmed speakers and full agenda are: \n\n\n\nWelcome and introduction  \n\n\n\nMarica Nobile (Assobiotec Federchimica) \n\n\n\nKeynote speech: EU biotech & biomanufacturing initiative  \n\n\n\nHans Ingels (DG GROW) \n\n\n\nPanel: Impact of EU Legislation on Investment Opportunities  \n\n\n\nYordan Aleksandrov (Pfizer) \n\n\n\nSME – Anna Handschuh (Future Affairs) \n\n\n\nNicoló Giacomuzzi-Moore (CBEJU) \n\n\n\nKatrien Swerts (Kurma Partners) \n\n\n\nMarica Nobile (Assobiotec Federchimica) will moderate the panel and deliver closing remarks. \n\n\n\n \n\n\n\n \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/the-future-of-biotech-the-role-of-legislation-on-investment-for-innovation/
CATEGORIES:Biotech Week,EuropaBio
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/06/GENERAL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240710T080000
DTEND;TZID=Europe/Brussels:20240711T170000
DTSTAMP:20260526T143102
CREATED:20240531T135225Z
LAST-MODIFIED:20240531T135227Z
UID:7893-1720598400-1720717200@www.europabio.org
SUMMARY:CURIOUS­ FUTURE INSIGHT™ CONFERENCE
DESCRIPTION:Over the millennia science & technology have steadily advanced\, but key unsolved challenges remain\, and much more is possible. The Curious – Future Insight™ Conference brings together some of the world’s brightest scientists and most accomplished innovators to present their work and explore the future of science and technology\, solving the challenges of today and enabling the dreams of a better tomorrow. \n\n\n\nThe Curious – Future Insight™ conference featurestop speakers and Nobel laureates from all over theworld\, among them: \n\n\n\n\nEmmanuelle Charpentier\, MPI (2018)\n\n\n\nSteven Chu\, Stanford University (2024)\n\n\n\nRobert Langer\, MIT (2024)\n\n\n\nSatya Nadella\, CEO Microsoft (2018)\n\n\n\nUğur Şahin\, CEO BioNTech (2024)\n\n\n\nRandy Schekman\, Berkeley (2024)\n\n\n\nThomas C. Südhof\, Stanford University (2024\, 2022)\n\n\n\nCraig Venter\, Craig Venter Institute (2018)
URL:https://www.europabio.org/event/curious-future-insight-conference/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Curious-Insights-Banner-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240626T170000
DTEND;TZID=Europe/Brussels:20240626T190000
DTSTAMP:20260526T143102
CREATED:20240429T092024Z
LAST-MODIFIED:20240513T092250Z
UID:7743-1719421200-1719428400@www.europabio.org
SUMMARY:NAC Belgian Presidency Summer Reception
DESCRIPTION:EuropaBio\, bio.be/essenscia\, and flanders.bio biotechnology associations are organising a summer reception in Brussels for its members and invited guests to mark the end of the Belgium Council Presidency of the European Union and celebrate what best is made in Belgium – (beyond waffles and beers)\, biotechnology! \n\n\n\nWe will present the outcomes of our National Associations Council Presidency Summit “Made in Belgium for Europe“\, with recommendations on advanced therapies for rare diseases and microorganisms’ role in agricultural applications.  \n\n\n\nIf you wish for more details\, please reach out to communications@europabio.org
URL:https://www.europabio.org/event/nac-belgian-presidency-summer-reception/
CATEGORIES:EuropaBio
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/04/Untitled-1-NAC-RECEPTION.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240613T113000
DTEND;TZID=Europe/Brussels:20240613T130000
DTSTAMP:20260526T143102
CREATED:20240513T142126Z
LAST-MODIFIED:20240513T142128Z
UID:7789-1718278200-1718283600@www.europabio.org
SUMMARY:Industrial Biotechnology Day (2nd edition) - Biotechnology as key enabling technology for EU Strategies and Ambitions
DESCRIPTION:Explore how industrial biotechnologies can achieve Europe’s environmental ambitions. Discussions will centre on exploring both regulatory frameworks and technological advancements\, identifying our core strengths and opportunities\, and pinpointing areas for improvement. From evaluating feedstocks and industrial capabilities to overcoming regulatory challenges\, join us in shaping a sustainable path forward for the European chemical industry through biotech innovations. \n\n\n\nThis session is organised by Cefic Sector Groups: EFCG\, EFG and Biochem Europe; EuropaBio and SICOS. \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/industrial-biotechnology-day-2nd-edition-biotechnology-as-key-enabling-technology-for-eu-strategies-and-ambitions/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Healthcare-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240516T090000
DTEND;TZID=Europe/Brussels:20240516T180000
DTSTAMP:20260526T143102
CREATED:20240118T152254Z
LAST-MODIFIED:20240118T152720Z
UID:7279-1715850000-1715882400@www.europabio.org
SUMMARY:Knowledge for Growth
DESCRIPTION:Get ready for the touchdown of Europe’s finest life sciences conference\, Knowledge for Growth\, on May 16\, 2024\, in the vibrant city of Antwerp\, Belgium!Elevate your network by rubbing shoulders with decision-makers from biotech\, pharma\, and MedTech\, alongside investors\, universities\, cutting-edge research institutes\, policymakers\, and competence providers. Join over 1000 life sciences trailblazers representing 500+ companies & organizations! Uncover the future with our riveting programme\, delivering key insights into the global and regional life sciences landscape. Engage in dynamic B2B partnering\, explore groundbreaking innovations at the trade fair\, and seize endless networking opportunities.Ready to be part of the life sciences revolution? Secure your spot now here! #KnowledgeForGrowth #KFG2024  \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/knowledge-for-growth-2/
LOCATION:Flanders Meeting & Convention Center Antwerp
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/Event-Banners-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240514T200000
DTEND;TZID=Europe/Brussels:20240515T180000
DTSTAMP:20260526T143102
CREATED:20240311T142703Z
LAST-MODIFIED:20240311T142744Z
UID:7536-1715716800-1715796000@www.europabio.org
SUMMARY:AseBio Investor Day
DESCRIPTION:We are thrilled to announce that AseBio will hold the fifth edition of the AseBio Investor Day at the gorgeous Kursaal conference center in San Sebastián (Spain) on the 15th of May. The AseBio Investor Day is a forum that aims to connect the Spanish biotechnology industry with national and international investors. \n\n\n\nSince its first edition (Barcelona\, 2017)\, the event has attracted national and international investors\, contributing to give visibility to the national biotechnology industry. AseBio Investor Day also fosters networking between investors from Spain and the rest of the world. \n\n\n\nAseBio Investor Day includes a program of round tables where relevant topics on investment and finance will be addressed\, one-to-one meetings and startup pitch presentations. There will also be socials where you can meet your peers and biotech entrepreneurs. \n\n\n\nMeeting Spanish biotechnology is an opportunity to access new deal flow opportunities. Spain is the 9th largest originator of knowledge in biotechnology by number of papers. As of 2023 there were about 900 firms fully dedicated to biotechnology and 270 firms partially dedicated to biotechnology. In 2022 the sector attracted €142 million. \n\n\n\nIn our last edition more than 260 attendees participated in Investor Day and more than 330 one-to-one meetings were held through our matchmaking tool. \n\n\n\nSan Sebastián is a beautiful coastal town in the Spanish Basque Country. The city boasts stunning beaches\, a rich gastronomical tradition with one to the highest densities of Michelin star restaurants in the world\, splendid architecture and a thriving cultural life. The event will take place immediately after BioEquity\, which this year will be held on May 14 and May 15 in the same venue. \n\n\n\nIf you are planning to attend BioEquity why not extend your stay one more day and join us for an opportunity to meet Spanish biotechnology. Investors are cordially invited to participate in the AseBio Investor Day 2024. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/asebio-investor-day/
LOCATION:Kursaal Zurriola Hiribidea\, 1 20002 Donostia\, Guipuzkoa (Spain)
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/03/Healthcare.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240507T140000
DTEND;TZID=Europe/Brussels:20240507T150000
DTSTAMP:20260526T143102
CREATED:20240429T082059Z
LAST-MODIFIED:20240429T084605Z
UID:7736-1715090400-1715094000@www.europabio.org
SUMMARY:Biomanufacturing Policy Summit - Report Launch
DESCRIPTION:“Policy pathways for biomanufacturing in Europe” was the theme of the Biomanufacturing Policy Summit 2024. The upcoming report will summarise the Summit’s keynote speeches and panel discussions and translate them into an analysis to Europe’s biomanufacturing strengths\, weaknesses\, opportunities and threats based on specific policies and industrial examples. \n\n\n\nThe report launch will also feature speakers who will respond to the report’s main conclusions and comment on their alignment with current challenges and future goals. \n\n\n\n\nHanna Freienstein\, Policy Officer\, DG GROW – European Commission\n\n\n\n⁠Jérôme Fabiano\, Deputy Director & Corporate Affairs Director\, EIT Health France\n\n\n\n⁠Per Falholt\, Chief Science Officer\, 21st.BIO\n\n\n\n\nThe boost to biotech and biomanufacturing needs a strong knowledge-based approach and the upcoming report aims to contribute to the discussion. Do not miss the opportunity and be up to date about biomanufacturing in Europe.
URL:https://www.europabio.org/event/europabios-biomanufacturing-policy-summit-report-launch/
CATEGORIES:Biomanufacturing Platform,EuropaBio
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/04/Untitled-600-x-200-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240416T083000
DTEND;TZID=Europe/Brussels:20240416T120000
DTSTAMP:20260526T143102
CREATED:20240326T082922Z
LAST-MODIFIED:20240326T083218Z
UID:7614-1713256200-1713268800@www.europabio.org
SUMMARY:RARE DISEASES FORUM 2024
DESCRIPTION:Against the backdrop of the Belgian EU Council Presidency\, the Rare Diseases Forum 2024 brings together senior leaders from across patient organisations\, industry and policy to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda. \n\n\n\n \n\n\n\nAbout ‘The Rare Diseases Forum 2024: Securing Europe’s Competitiveness in R&D for people living with rare diseases’ features keynotes and panel discussions with a focus on the EU’s role in enhancing competitiveness in life sciences\, fostering investment in the rare diseases sector\, and examining the benefits of a competitive agenda for those with rare diseases.  \n\n\n\nThe event is convened by Global Counsel on behalf of the forum partners\, EURORDIS\, RaDiOrg\, EFPIA\, Eucope\, EuropaBio\, Pharma.be\, UCB\, Novo Nordisk\, Sanofi & Takeda.
URL:https://www.europabio.org/event/rare-diseases-forum-2024/
CATEGORIES:EuropaBio,External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/03/Event-Banner-Website-updated.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240319T143000
DTEND;TZID=Europe/Brussels:20240319T164500
DTSTAMP:20260526T143102
CREATED:20240213T092326Z
LAST-MODIFIED:20240213T093923Z
UID:7402-1710858600-1710866700@www.europabio.org
SUMMARY:Industrial biotech: Is Europe ready to harness its potential?
DESCRIPTION:A Science | Business closed-door roundtable\, organised in partnership with EuropaBio – followed by networking reception \n\n\n\nOnly By Invitation \n\n\n\n \n\n\nBackground Information \nIn recent years industrial biotechnology – also known as “white” biotech – has emerged as a high-value driver of industrial modernisation and the green transition. Through the innovative use of microorganisms and enzymes\, it has transformative potential for manufacturing\, waste use and the creation of sustainable products in sectors as varied as energy\, textiles\, plastics\, paper\, agriculture and water. While some core processes\, such as fermentation technology\, have been commercially deployed for around 50 years\, the speed of scientific progress and solution development are accelerating exponentially. As such\, it appears that the sector as a whole is truly poised to make the leap from “proof of concept” to mainstream application at the European level.  \nThese take on greater importance when one considers other strategic priorities for the EU. First\, it is clear that for Europe to achieve e.g. its 2030 benchmark for net-zero technology manufacturing in the Green Deal Industrial Plan (GDIP)\, it will need to leverage its full innovation capacity across sectors. Second\, as global demand grows for sustainable solutions to climate\, energy\, biodiversity and food system crises\, Europe is ideally positioned to take market leadership in various domains\, given its research excellence and strong industrial base. And third\, the EU’s proposed Strategic Technologies for Europe Platform (STEP) has already identified biotechnologies among its key value chains to ensure future resilience\, autonomy and competitiveness\, while biotechnology has also been recognised as a critical technology for Europe. \nYet a degree of skepticism remains – both in public and policy circles – about the risk/reward ratio of biotechnologies and their wider value to society. One useful counterpoint is to consider the evolution of health-related biotechnology (often called “red” biotech). Having overcome similar resistance and concerns\, “red” biotech is now deployed at scale throughout the life science and pharmaceutical sectors\, and is acknowledged today as a key component in European health innovation. So how can the lessons learned on that journey be absorbed and applied to other sectors?   \n As the EU prepares for its transition to a new Parliament and Commission\, it is therefore an ideal moment to open a multistakeholder dialogue on how policy and regulatory innovations could increase the European added value of “white” biotech and biomanufacturing in the years to come. This also builds on Ursula von der Leyen’s announcement of a new biotech and biomanufacturing initiative in last September’s state-of-the-union address. Among some of the key issues for consideration: \nWhere can industrial biotech and biomanufacturing contribute most effectively to the GDIP and STEP\, and what are the longer-term implications for boosting the global competitiveness of European companies?\nWhat should underpin a future EU roadmap for advancing “white” biotech and biomanufacturing across sectors\, in line with other long-term strategies and objectives?\nWhich other steps are needed at EU and national level to build future capacity\, such as infrastructure and skills?\nIn which ways can public and private finance best support pioneering “white” biotech firms – large and small – in scaling up and maturing their solutions to market-readiness and mass production levels\, as has happened in the health sector?\nBeyond the CBE Joint Undertaking\, to what extent could Horizon Europe\, FP10 and other key instruments – such as the new biotech & biomanufacturing initiative – strengthen Europe’s industrial biotech R&D ecosystem in the next policy cycle?\nOn March 19\, Science|Business\, in cooperation with EuropaBio\, will convene a select group of senior figures and experts from across the industrial biotech spectrum to address these issues in a closed-door\, invitation-only roundtable. Drawing in part on latest research and real-world applications\, the meeting will identify recommendations to harness the full potential of “white” biotech and biomanufacturing\, and to align its further development with the realisation of key EU policy goals.\n \n \n\n\n\n\n\n\n \n\n\n\n \n\n\n\nFor more information\, please contact: denitsa.nikolova@sciencebusiness.ne \n\n\n\n \n\n\n\n \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/industrial-biotech-is-europe-ready-to-harness-its-potential/
CATEGORIES:EuropaBio,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/02/Event-Banners-Website-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240313T130000
DTEND;TZID=Europe/Brussels:20240313T200000
DTSTAMP:20260526T143102
CREATED:20231213T100000Z
LAST-MODIFIED:20240209T113124Z
UID:7082-1710334800-1710360000@www.europabio.org
SUMMARY:Biomanufacturing Policy Summit 2024 - Policy pathways for biomanufacturing in Europe
DESCRIPTION:The Biomanufacturing Policy Summit will host its 2nd edition in March 2024. The invite-only half-day summit hosted by EuropaBio brings together stakeholders including industry representatives and policymakers\, to discuss Europe’s ambitions for biomanufacturing and the tangible legislative\, regulatory and strategic pathways. \n\n\n\n2023 was a year of visibility and recognition for biomanufacturing in Europe. It saw the creation of the Strategic Technologies for Europe Platform (STEP) and the announcement of the EU Biotech and Biomanufacturing Initiative\, plus the identification of biotechnology as a critical technology for Europe’s security. 2024 is expected to be a year in which initiatives gain policy momentum\, within a new Parliament and Commission and begin to deliver practical and impactful instruments to European industries. \n\n\n\n \n\n\n\n13:00 – Lunch14:00 – Welcome & Introduction14:10 – Keynote Speakers15:30 – Defragmenting and Accelerating Europe’s Biotech & Biomanufacturing – The Role of Policy “How does policy impact decisions for biomanufacturing companies in Europe across sectors?”16:15 – Coffee Break16:30 – Out of the Box – A Global View on Biomanufacturing Policies “What can Europe learn and lead from policy across global regions?”17:15 – How does Policy deliver for Biomanufacturing – Looking Ahead “The policy future for Europe\, with recommendations for the incoming Commission and Parliament.”18:00 – Networking Reception \n\n\n\n \n\n\n\nParticipants will discuss how policy enables Europe to seize the opportunity for biomanufacturing within innovative\, sustainable and critical products within global supply chains. The Summit will address policy pathways for how biotech and biomanufacturing can deliver results in competitiveness\, Green Transition and resilience across sectors. \n\n\n\nFor all enquiries\, please contact our Biomanufacturing Platform Coordinator\, Francisco Castro Alves: f.alves@europabio.org
URL:https://www.europabio.org/event/biomanufacturing-policy-summit-2024-policy-pathways-for-biomanufacturing-in-europe/
CATEGORIES:Biomanufacturing Platform,EuropaBio
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/12/Event-Banner-2.png
END:VEVENT
END:VCALENDAR